Short Interest Don’t Lie: Could Dentsply Sirona Incorporated (NASDAQ:XRAY) Go Up After Its Newest Short Interest Report?

November 22, 2016 - By Pete Kolinski   ·   0 Comments

Short Interest Don't Lie: Could Dentsply Sirona Incorporated (NASDAQ:XRAY) Go Up After Its Newest Short Interest Report?

The stock of Dentsply Sirona Incorporated (NASDAQ:XRAY) registered an increase of 9.27% in short interest. XRAY’s total short interest was 6.47M shares in November as published by FINRA. Its up 9.27% from 5.92 million shares, reported previously. With 1.14M shares average volume, it will take short sellers 6 days to cover their XRAY’s short positions. The stock decreased 0.47% or $0.28 during the last trading session, hitting $59.88. DENTSPLY SIRONA Inc (NASDAQ:XRAY) has declined 2.27% since April 20, 2016 and is downtrending. It has underperformed by 6.82% the S&P500.

DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., designs, develops, makes and markets a range of consumable dental products for the professional dental market. The company has a market cap of $13.65 billion. The Firm also makes and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. It has a 30.75 P/E ratio. The Company’s divisions include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses.

Insitutional Activity: The institutional sentiment increased to 0.45 in Q2 2016. Its up 0.19, from 0.26 in 2016Q1. The ratio improved, as 12 funds sold all DENTSPLY SIRONA Inc shares owned while 7 reduced positions. 3 funds bought stakes while 2 increased positions. They now own 2.10 million shares or 26.85% less from 2.88 million shares in 2016Q1.
Lmr Partners Ltd Liability Partnership holds 0.13% of its portfolio in DENTSPLY SIRONA Inc (NASDAQ:XRAY) for 13,795 shares. Alleghany Corporation De holds 3.81% or 1.60 million shares in its portfolio. Tirschwell & Loewy holds 1.67% of its portfolio in DENTSPLY SIRONA Inc (NASDAQ:XRAY) for 153,769 shares. Df Dent And last reported 0.01% of its portfolio in the stock. The Idaho-based Buffington Mohr Mcneal has invested 0.22% in DENTSPLY SIRONA Inc (NASDAQ:XRAY). Westport Resources Mgmt has 7,300 shares for 0.15% of their US portfolio. Cardinal Management reported 67,070 shares or 1.69% of all its holdings. The Massachusetts-based De Burlo has invested 1.98% in DENTSPLY SIRONA Inc (NASDAQ:XRAY). Liberty Cap Management holds 0.57% of its portfolio in DENTSPLY SIRONA Inc (NASDAQ:XRAY) for 13,550 shares. Huntington Comml Bank accumulated 0.01% or 5,950 shares. Palo Cap reported 40,422 shares or 0.86% of all its holdings. Janney Montgomery Scott Ltd Liability, a Pennsylvania-based fund reported 7,128 shares. West Oak Lc holds 0% of its portfolio in DENTSPLY SIRONA Inc (NASDAQ:XRAY) for 21,540 shares. Wendell David Assocs has invested 0.35% of its portfolio in DENTSPLY SIRONA Inc (NASDAQ:XRAY). The California-based Gemmer Asset Management Lc has invested 0.01% in DENTSPLY SIRONA Inc (NASDAQ:XRAY).

Insider Transactions: Since May 25, 2016, the stock had 0 insider buys, and 5 sales for $7.84 million net activity. CLARK CHRISTOPHER T sold $3.61M worth of stock or 59,300 shares. The insider ALFANO MICHAEL C sold $127,159. 17,650 shares were sold by MacInnis Maureen J., worth $1.07M. 5,000 shares were sold by Berthan Rainer, worth $305,597 on Tuesday, September 6.

DENTSPLY SIRONA Inc (NASDAQ:XRAY) Ratings Coverage

Out of 12 analysts covering Dentsply International (NASDAQ:XRAY), 8 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 67% are positive. Dentsply International has been the topic of 18 analyst reports since August 3, 2015 according to StockzIntelligence Inc. UBS upgraded the shares of XRAY in a report on Thursday, February 25 to “Neutral” rating. William Blair downgraded the shares of XRAY in a report on Monday, March 14 to “Market Perform” rating. The stock of DENTSPLY SIRONA Inc (NASDAQ:XRAY) earned “Overweight” rating by Morgan Stanley on Monday, September 14. The firm has “Equal-Weight” rating by Morgan Stanley given on Thursday, March 24. The firm has “Outperform” rating given on Monday, September 21 by Northcoast. The rating was upgraded by Robert W. Baird on Wednesday, September 16 to “Outperform”. The firm earned “Hold” rating on Wednesday, August 19 by Zacks. The rating was maintained by Bank of America with “Buy” on Wednesday, September 16. The firm earned “Hold” rating on Thursday, September 3 by Zacks. The firm has “Outperform” rating by Barrington Research given on Friday, May 13.

XRAY Company Profile

DENTSPLY SIRONA Inc., formerly DENTSPLY International Inc., incorporated on February 15, 1983, designs, develops, makes and markets a range of consumable dental products for the professional dental market. The Firm also makes and markets consumable medical device products consisting mainly of urological catheters and certain surgical products. The Company’s divisions include Dental Consumables, Endodontic and Dental Laboratory Businesses; Healthcare, Orthodontic and Implant Businesses, and Select Developed and Emerging Markets Businesses. The Company’s principal product categories are dental consumable products, dental laboratory products, dental specialty products and consumable medical device products. The Firm distributes its products in over 120 countries.

More important recent DENTSPLY SIRONA Inc (NASDAQ:XRAY) news were published by: Wsj.com which released: “Dentsply Sirona to Buy MIS Implants for $375 Million” on June 27, 2016, also Nasdaq.com published article titled: “DENTSPLY SIRONA is Now Oversold (XRAY)”, Seekingalpha.com published: “Dentsply Sirona’s (XRAY) CEO Jeffrey Slovin on Q2 2016 Results – Earnings Call …” on August 05, 2016. More interesting news about DENTSPLY SIRONA Inc (NASDAQ:XRAY) was released by: Investorplace.com and their article: “Trade of the Day: A Look at XRAY Stock Shows Huge Promise” with publication date: June 10, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Pete Kolinski


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>